CancerCancerCancer and Cell BiologyDisease AreaImmunotherapyLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearchTumoursxOncofetal Ecosystem
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
CancerCancerImmunotherapyLiver CancerMedia ReleasesMelanomaMelanoma DiscoveryMelonomaNews & EventsResearchTranslationTumours
WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…
Bowel CancerBreast CancerCancerCancerCancer and Cell BiologyCancer Centre NewsColorectal CancerEndometrial CancerHead and NeckLiver CancerLiver CancerLungsMelanomaMelonomaNews & EventsOvarian CancerProstate CancerProstate CancerTumours
Cancer researchers welcome Federal funding for WA centre
By Richard Schoonraad | Bowel Cancer, Breast Cancer, Cancer, Cancer, Cancer and Cell Biology, Cancer Centre News, Colorectal Cancer, Endometrial Cancer, Head and Neck, Liver Cancer, Liver Cancer, Lungs, Melanoma, Melonoma, News & Events, Ovarian Cancer, Prostate Cancer, Prostate Cancer, TumoursWestern Australians living with cancer to receive patient centred care linked to research. Fast facts: Cancer is a major cause of death by disease in adults and children in Australia…
Blood VesselsCancerLabNews & EventsResearchTumour Blood VesselsTumoursVascular Biology and Stromal Targeting
New drug limits cancer spreading
By Alicia Bienkowski | Blood Vessels, Cancer, Lab, News & Events, Research, Tumour Blood Vessels, Tumours, Vascular Biology and Stromal TargetingMost patients die from metastatic cancers, not the primary tumour A research team that recently invented a drug to stop blood vessels from forming a treatment resistant barrier around some…
CancerLabNews & EventsTumours
New drug that breaks down the ‘barbed wire’ around some cancers
By Alicia Bienkowski | Cancer, Lab, News & Events, TumoursPerth researchers discover way to enhance immune response and drug treatment of stiff, difficult-to-treat solid cancers Some solid tumours are so stiff they make a cracking noise when they are…
Cancer and Cell BiologyDisease AreaLabNews & EventsResearchResearch AreaTumoursVascular Biology and Stromal Targeting
New collaboration to aid the development of drugs to treat cancers
By Marlin Communications | Cancer and Cell Biology, Disease Area, Lab, News & Events, Research, Research Area, Tumours, Vascular Biology and Stromal TargetingCancer immunotherapies, including checkpoint blocking antibodies such as MSD’s Keytruda, have shown remarkable results in a number of different cancer types. However the effectiveness of these treatments may be enhanced…
Disease AreaMedia ReleasesNews & EventsTumours
New facility for Perth melanoma patients
By Marlin Communications | Disease Area, Media Releases, News & Events, TumoursThe new WA Kirkbride Melanoma Advisory Service (WAKMAS) combines the WA Melanoma Advisory Service (WAMAS), which has been operating at St John of God Hospital, and the Kirkbride Melanoma Centre…
Cancer and Cell BiologyDisease AreaNews & EventsResearchResearch AreaTumours
New drug to supercharge immune cells in the fight against cancer
By Marlin Communications | Cancer and Cell Biology, Disease Area, News & Events, Research, Research Area, TumoursMany tumours can become resistant to the body’s immune system by creating a barrier of tangled blood vessels that feed the tumour while locking out immune cells that would attack…
